DE2740041A1 - 5-Hydroxy-4,4-di:methyl-1,3-dioxan and its ester(s) - prepd. e.g. from Celastrus paniculatus seed oil and having psycho-pharmaceutical esp. memory enhancing activity - Google Patents
5-Hydroxy-4,4-di:methyl-1,3-dioxan and its ester(s) - prepd. e.g. from Celastrus paniculatus seed oil and having psycho-pharmaceutical esp. memory enhancing activityInfo
- Publication number
- DE2740041A1 DE2740041A1 DE19772740041 DE2740041A DE2740041A1 DE 2740041 A1 DE2740041 A1 DE 2740041A1 DE 19772740041 DE19772740041 DE 19772740041 DE 2740041 A DE2740041 A DE 2740041A DE 2740041 A1 DE2740041 A1 DE 2740041A1
- Authority
- DE
- Germany
- Prior art keywords
- acid
- ester
- dioxan
- dimethyl
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000002148 esters Chemical class 0.000 title claims description 12
- 240000006739 Celastrus paniculatus Species 0.000 title abstract description 6
- 235000017186 Celastrus paniculatus Nutrition 0.000 title abstract description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 title description 2
- 230000000694 effects Effects 0.000 title 1
- 230000006883 memory enhancing effect Effects 0.000 title 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 26
- -1 aliphatic monocarboxylic acid Chemical class 0.000 claims abstract description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 230000001476 alcoholic effect Effects 0.000 claims abstract description 6
- 230000032050 esterification Effects 0.000 claims abstract description 5
- 238000005886 esterification reaction Methods 0.000 claims abstract description 5
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims abstract description 4
- 229960004488 linolenic acid Drugs 0.000 claims abstract description 4
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims abstract description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims abstract description 3
- 125000003118 aryl group Chemical group 0.000 claims abstract description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Substances [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims abstract description 3
- 239000010685 fatty oil Substances 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- AMZPQUQKCZCMEH-UHFFFAOYSA-N 4,4-dimethyl-1,3-dioxan-5-ol Chemical compound CC1(OCOCC1O)C AMZPQUQKCZCMEH-UHFFFAOYSA-N 0.000 claims description 8
- 238000004821 distillation Methods 0.000 claims description 8
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 8
- 150000002012 dioxanes Chemical class 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 3
- KKFDJZZADQONDE-UHFFFAOYSA-N (hydridonitrato)hydroxidocarbon(.) Chemical compound O[C]=N KKFDJZZADQONDE-UHFFFAOYSA-N 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims 3
- 150000005840 aryl radicals Chemical class 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 229940126601 medicinal product Drugs 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract description 3
- 229930040373 Paraformaldehyde Natural products 0.000 abstract description 3
- 235000021355 Stearic acid Nutrition 0.000 abstract description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 abstract description 3
- 229920002866 paraformaldehyde Polymers 0.000 abstract description 3
- 239000008117 stearic acid Substances 0.000 abstract description 3
- 229960003512 nicotinic acid Drugs 0.000 abstract description 2
- 235000001968 nicotinic acid Nutrition 0.000 abstract description 2
- 239000011664 nicotinic acid Substances 0.000 abstract description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract description 2
- 125000002252 acyl group Chemical group 0.000 abstract 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- VDFVNEFVBPFDSB-UHFFFAOYSA-N 1,3-dioxane Chemical compound C1COCOC1 VDFVNEFVBPFDSB-UHFFFAOYSA-N 0.000 abstract 1
- UEBARDWJXBGYEJ-UHFFFAOYSA-N 2-bromo-3-methylbutanoic acid Chemical compound CC(C)C(Br)C(O)=O UEBARDWJXBGYEJ-UHFFFAOYSA-N 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 229960004274 stearic acid Drugs 0.000 abstract 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 238000007127 saponification reaction Methods 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229910052681 coesite Inorganic materials 0.000 description 3
- 229910052906 cristobalite Inorganic materials 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 229910052682 stishovite Inorganic materials 0.000 description 3
- 229910052905 tridymite Inorganic materials 0.000 description 3
- LVRIOILOUAJGGN-UHFFFAOYSA-N 2-methyl-1-(2-methylpropoxymethoxy)propane Chemical compound CC(C)COCOCC(C)C LVRIOILOUAJGGN-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 238000012746 preparative thin layer chromatography Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- LSPHULWDVZXLIL-LDWIPMOCSA-N (?)-Camphoric acid Chemical compound CC1(C)[C@@H](C(O)=O)CC[C@@]1(C)C(O)=O LSPHULWDVZXLIL-LDWIPMOCSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
- BWWHTIHDQBHTHP-UHFFFAOYSA-N 2-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC=CC=C1C(Cl)=O BWWHTIHDQBHTHP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- VFZDNKRDYPTSTP-UHFFFAOYSA-N 5,8,8-trimethyl-3-oxabicyclo[3.2.1]octane-2,4-dione Chemical compound O=C1OC(=O)C2(C)CCC1C2(C)C VFZDNKRDYPTSTP-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- ZETHHMPKDUSZQQ-UHFFFAOYSA-N Betulafolienepentol Natural products C1C=C(C)CCC(C(C)CCC=C(C)C)C2C(OC)OC(OC)C2=C1 ZETHHMPKDUSZQQ-UHFFFAOYSA-N 0.000 description 1
- 101100380339 Brassica napus Bp10 gene Proteins 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- DUCNKBZIKNAQOS-UHFFFAOYSA-N O=[C]C1=CC=CN=C1 Chemical compound O=[C]C1=CC=CN=C1 DUCNKBZIKNAQOS-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 238000003436 Schotten-Baumann reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- HEOKFDGOFROELJ-UHFFFAOYSA-N diacetal Natural products COc1ccc(C=C/c2cc(O)cc(OC3OC(COC(=O)c4cc(O)c(O)c(O)c4)C(O)C(O)C3O)c2)cc1O HEOKFDGOFROELJ-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 239000000295 fuel oil Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229940035429 isobutyl alcohol Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- JJAIIULJXXEFLV-UHFFFAOYSA-N pentane-2,3,4-triol Chemical compound CC(O)C(O)C(C)O JJAIIULJXXEFLV-UHFFFAOYSA-N 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 229940001470 psychoactive drug Drugs 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Dioxanderivate und Verahren zu deren Herstellung. Dioxane derivatives and processes for their production.
Gegenstand der vorliegenden Erfindung sind Dioxanderivate der allgemeinen Formel worin R ein Wasserstoffatom, den Acylrest einer gesättigten oder ungesättigten aliphatischen Monocarbonsäure, insbesondere den Acylrest einer gesättigten oder ungesättigten Fettsäure mit etwa 16 bis 22 Kohlenstoffatomen oder den Acylrest einer phemakologisch unbedenklichen aromatischen, sraliphatischen, cycloaliphatischen oder heterocyclischen Carbosäure, insbesondere den Furoyl-(2)-rest, den Benzyolrest, den Nicotinoylrest, den Campheroylrest, den α-Bromisoranyleriaroylrest oder den Carbamoylrest bedeutet, Beispiele für geeignete gesättigte Fettsäuren sind Stearinsäure, Palmitinsäure, Arachinsäure, Nargarinsäure und Behensaure.The present invention relates to dioxane derivatives of the general formula wherein R is a hydrogen atom, the acyl radical of a saturated or unsaturated aliphatic monocarboxylic acid, in particular the acyl radical of a saturated or unsaturated fatty acid with about 16 to 22 carbon atoms or the acyl radical of a phemacologically harmless aromatic, sraliphatic, cycloaliphatic or heterocyclic carboxylic acid, especially the furoyl (2) radical, the benzyol radical, the nicotinoyl radical, the campheroyl radical, the α-bromoisoranyleriaroyl radical or the carbamoyl radical, examples of suitable saturated fatty acids are stearic acid, palmitic acid, arachidic acid, nargaric acid and behenic acid.
Beispiele für geeignete ungesättigte Fettsäuren sind Ölsäure, Linolsäure, Linolensäure und Rizinolsäure sowie Pnlmitölsäure, Petrosilinsaure und Erucasäure.Examples of suitable unsaturated fatty acids are oleic acid, linoleic acid, Linolenic acid and ricinoleic acid as well as mitoleic acid, petrosilic acid and erucic acid.
Die erfindungsgemäßen Verbindungen sind als Psychopharmaka wertvoll. Sie besitzen insbesondere gedächtnisstimulierende Eigenschaften, d.h. sie dienen zur Verbesserung der Merkfähigkeit und des Lernvermögens.The compounds of the invention are valuable as psychotropic drugs. In particular, they have memory-stimulating properties, i.e. they serve to improve memory and learning.
Die erfindungsgemäßen Verbindungen können aus Öl, das aus den Samen von Celastrus paniculatus ausgepreßt wurde, gewonnen werden. Dieses Öl wird in asiatischen Ländern und in Indien hauptsächlich als Brennöl verwendet, allerdings gilt das Öl in der Volksmedizin auch als mildes Nervinum.The compounds of the invention can be obtained from oil obtained from the seeds squeezed by Celastrus paniculatus. This oil is made in Asian Countries and in India mainly used as fuel oil, but the oil counts in folk medicine also as mild nervinum.
Die Verbindungen können dadurch erhalten werden, dan man kalt gepreßtes fettes Samenöl von Celastnus paniculatus mit o,5 N, gegebenenfalls alkoholischer Enlil.auge oder Natronlauge verseilt, darauf ansäuert und mit Äther nusschüttelt, aus der wässrigen, die Dioxanverbindungen enthaltenden Phase das Wasser verdampft und aus dem Rückstand in an sich bekannter Weise das geminschte Produkt gewinnt, wobei, wenn R der Formel ein Wasserstoffatom bedeutet, die Verbindung durch Destillation aus dem Rückstand erhalten wird, und wenn R der Formel die vorstehend angegebenen Acylreste bedeutet, die gewünschten Verbindungen durch Destillation aus dem Rückstand und anschließendes Verestern der Verbindungen oder erst Verestern des Rückstandes und anschließende Destillation des veresterten Produktes gewonnen werden.The compounds can be obtained by cold-pressing fatty seed oil from Celastnus paniculatus with 0.5N, alcoholic if necessary Enlil.auge or caustic soda stranded, then acidified and shaken with ether, the water evaporates from the aqueous phase containing the dioxane compounds and the mined product is obtained from the residue in a known manner, where, when R of the formula is a hydrogen atom, the compound by distillation is obtained from the residue, and when R of the formula those given above Acyl radicals means the desired compounds by distillation from the residue and subsequent esterification of the compounds or first esterification of the residue and subsequent distillation of the esterified product can be obtained.
Die Verseifung des Öles mit o,5 N, gegebenenfalls alkoholischer Kalilauge oder Natronlauge erfolgt meist bei 80 bis 100° C, wobei im Wasserbad gearbeitet wird.The saponification of the oil with 0.5 N, optionally alcoholic potassium hydroxide solution or sodium hydroxide solution is usually carried out at 80 to 100 ° C, working in a water bath will.
Zum Ansäuern kann Jede geeignete Säure verwendet werden.Any suitable acid can be used for acidification.
Vorzugsweise wird l N Salzsäure verwendet. Die Überführung des freien Alkohols in die entsprechenden gewiinschten Ester erfolgt nach an sich bekannten Verfahren, z.B. nach Schotten-Baumann unter Verwendung der entsprechenden Acylhalogenide in Gegenwart verdünnter Alkalien oder eines tertiären Amins oder anderen üblichen Veresterungsverfahren.1 N hydrochloric acid is preferably used. The transfer of the free Alcohol into the corresponding desired esters is carried out according to known methods Method, e.g. according to Schotten-Baumann using the corresponding acyl halides in the presence of dilute alkalis or a tertiary amine or other customary Esterification process.
Die erfindungsgemäß eingesetzten Verbindungen können auch auf synthetischem Wege hergestellt werden.The compounds used according to the invention can also be based on synthetic Paths are made.
Das synthetische Verfahren zur Herstellung der Verbindungen ist dadurch gekennzeichnet, daß man 1,1-Dimethylglycerin in an sich bekannter Weise mit Paraformaldehyd oder einem seine Diacetale umsetzt, das erhaltene Isomerengemisch trennt und gegebenenfalls die dabei erhaltene Verbindung in an sich bekannter Weise in die entsprechenden Ester iiberfiihrt.The synthetic process for making the compounds is thereby characterized in that 1,1-dimethylglycerol in a known manner with paraformaldehyde or one of its diacetals is converted, the mixture of isomers obtained is separated and optionally the compound obtained in this way in a manner known per se into the corresponding Ester converted.
Dic Umsetzung wird meist ohne Lösungsmittel bei Temperaturen von 150 bis 1600 C oder in siedendem absolutem Benzol durchgefiihrt. Vorzugsweise werden pro Mol 1,1-Dimethylglycerin 1,2 Mol Paraformaldehyd oder eines der Diacetale, vorzugsweise das Di-t-butyldiacetal, verwendet.The implementation is usually carried out without a solvent at temperatures of 150 up to 1600 C or in boiling absolute benzene. Preferably be per mole of 1,1-dimethylglycerol, 1.2 moles of paraformaldehyde or one of the diacetals, preferably the di-t-butyl diacetal is used.
Gegebenenfalls kann die Umsetzung in Gegenwart von katalytischen Mengen p-Toluolsulfonsäure durchgefiihrt werden.The reaction can optionally be carried out in the presence of catalytic amounts p-Toluenesulfonic acid can be carried out.
Die Isomerentrennung erfolgt nach üblichen Methoden, beispielsweise durch fraktionierte Kristallisation oder Destillation oder durch Umsetzung mit optisch aktiven Partnern.The isomers are separated by customary methods, for example by fractional crystallization or distillation or by reaction with optical active partners.
Aus dem Alkohol werden die gewünschten Ester nach an sich bekannten Verfahren erhalten.The desired esters are obtained from the alcohol in accordance with known methods Procedure received.
Die nachfolgenden Beispiele dienen der Erläuterung der vorliegenden Erfindung.The following examples serve to illustrate the present Invention.
Beispiel 1 loo g Öl aus den Samen von Celastrus paniculatus werden während 4 Stunden mit 500 ml 1 N alkoholischer Natronlauge verseift und anschließend durch Destillation im Vakuum vom Alkohol befreit. Der Rückstand wird in 400 ml Wasser aufgenommen und 4 mal mit Äther extrahiert. Die Verseifungslauge wird mit 1 N Salzsäure genau neutralisiert und anschließend im Vakuum eingeengt. Der Rückstand (34.8 g) wird mit 80 m absolutem Methanol digeriert, das unlösliche NaCl abgesaugt und zweimal mit absolutem Methanol nachgewaschen. Die gesammelten Methanolextrakte werden eingeengt, wobei 3m,4 g eines leicht hraunen Öles zurückbleiben.Example 1 100 g of oil can be obtained from the seeds of Celastrus paniculatus saponified for 4 hours with 500 ml of 1 N alcoholic sodium hydroxide solution and then freed from alcohol by distillation in vacuo. The residue is dissolved in 400 ml of water added and extracted 4 times with ether. The saponification liquor is treated with 1 N hydrochloric acid exactly neutralized and then concentrated in vacuo. The residue (34.8 g) is digested with 80 m absolute methanol, the insoluble NaCl is suctioned off and twice washed with absolute methanol. The collected methanol extracts are concentrated, leaving 3m, 4 g of a slightly brown oil.
Das Öl wird mittels präparativer Dünnschichtchromatografie (SiO2 PF 254 (Merck):Benzol/Aceton 1:1) aufgetrennt.The oil is determined by means of preparative thin layer chromatography (SiO2 PF 254 (Merck): benzene / acetone 1: 1) separated.
Die Zone mit einem RF-Wert von o.34 - o.38 wird isoliert.The zone with an RF value of o.34 - o.38 is isolated.
1.5 g der aus dieser tone isolierten Substanz (erhalten aus weiteren Verseifungsreaktionen) wird mit 3.5 g Nitrobenzoylchlorid in Pyridin behandelt. Das Reaktionsprodukt (2.o g) wird mittels präparativer Dünnschichtchromatografie (SiO2 PF 254; Benzol/Äthylacetat 9:1) in drei Zonen getrennt.1.5 g of the substance isolated from this clay (obtained from further Saponification reactions) is treated with 3.5 g of nitrobenzoyl chloride in pyridine. The reaction product (2.o g) is determined by means of preparative thin layer chromatography (SiO2 PF 254; benzene / ethyl acetate 9: 1) separated into three zones.
Die zweite Zone, die Hauptfraktion, (RF: o.5) wird nochmals mittels Trockensäulenchromatographie getrennt. Der Rückstand (nach Elution des SiO2 mit Äthylacetat) ergab nach Umkristallisation o.31 g weiße Kristalle (Fp.p. 79-ôo° C).The second zone, the main fraction, (RF: o.5) is again using Separate dry column chromatography. The residue (after elution of the SiO2 with Ethyl acetate) gave, after recrystallization, 31 g of white crystals (melting point 79 ° -40 ° C.).
Die Analyse ergab: gefunden C : 47.85 io H : 4.36 % N : 8.46X ber. für C13H14N2O4:C: 48.59 %, H : 4,29%, N : 8,59 % Auf Grund der NMR- und massenpektrometrischen Daten der synthetischen 1,3 Dioxolan- und 1,3 Dioxan-alkohole wurde die Struktur des aus Colastrus-Öl erhaltenen Alkohol s als 414-Dimethyl-1,3-dioxan-5-ol festgestellt.The analysis showed: found C: 47.85 io H: 4.36% N: 8.46X calc. for C13H14N2O4: C: 48.59%, H: 4.29%, N: 8.59% On the basis of NMR and mass spectrometry Data of the synthetic 1,3 dioxolane and 1,3 dioxane alcohols was made the Structure of the alcohol obtained from Colastrus oil as 414-dimethyl-1,3-dioxan-5-ol established.
Beispiel 2 A) 300 Teile des Öls, das aus den Samen von Celastrus paniculatus ausgepreßt wurde, werden in bekannter Weise mit 6oo Teilen 5 N Natronlauge und t ooo Teilen Wasser verseift. Anschließend wird in der Siedehitze mit etwa 1 ooo Teilen Kochsalz ausgesalzen und der nach dem Erkalten erstarrende Seifenkuchen abgehoben.Example 2 A) 300 parts of the oil obtained from the seeds of Celastrus paniculatus was pressed out in a known manner with 600 parts of 5N sodium hydroxide solution and t ooo parts of water saponified. Then it is boiled with about 1,000 parts Salt out the table salt and lift off the soap cake, which has solidified after cooling.
B) 300 Teile des Öls, das aus den Samen von Celastrus paniculatus ausgepreßt wurde, werden in bekannter Weise mit 4 ooo Teilen o,5 N alkoholischer Knli- oder Natronlauge verseift und danach durch Destillation im Vakuum vom Alkohol befreit.B) 300 parts of the oil obtained from the seeds of Celastrus paniculatus was squeezed, are in a known manner with 4,000 parts o, 5 N alcoholic Saponified caustic soda or caustic soda and then distilled off the alcohol in vacuo freed.
Die nach A oder B gewonnene Verseifungslauge wird mit Salzsäure genau neutralisiert, die ausgeschidenen ergani schen Säuren werden abfil triert und/odor die Lauge wird zur Entfernung dieser Säuren mit maximal 250 Teilen Äther extrahiert. Die so behandelte wässrige Lauge wird anschließend im Vakuum eingedampft. Der während des Konzentrierens entstehende Niederschlag wird abgesaugt, mit ctwas Alkohol gewaschen, und das Filtrat wird möglichst vom Wasser befreit. Der Rückstand wird mit 150 Teilen eines Alkohol/ Äther-Gemisches digeriert und vom Unlöslichen abgesaugt.The saponification liquor obtained according to A or B is precise with hydrochloric acid neutralized, the excreted organic acids are filtered off and / or odorized To remove these acids, the lye is extracted with a maximum of 250 parts of ether. The aqueous alkali treated in this way is then evaporated in vacuo. The during the resulting precipitate is filtered off with suction, washed with a little alcohol, and the filtrate is freed from water as far as possible. The residue is 150 parts an alcohol / ether mixture digested and sucked off from the insoluble.
Das Filtrat wird so weit wie möglich eingeengt und der Rückstand im Vakuum fraktioniert. Die Fraktion zwischen Kp10 75 bis 90° C enthält vorbnehmlich das 4,4-Dimethyl-1,3 dioxan-5-ol, das durch wiederholte Destillation oder durch Umkristallisieren seiner Ester gereinigt wird.The filtrate is concentrated as much as possible and the residue in Vacuum fractionated. The fraction between Kp10 75 to 90 ° C mainly contains the 4,4-dimethyl-1,3 dioxan-5-ol, which by repeated distillation or by Recrystallize its ester is purified.
Das so erhaltene reine 4,4-Dimethy]-1,3-dioxan-5-ol (Ausbeute ca. 20 %) ist gekennzeichnet durch Kp10 75 bis 800 C.The pure 4,4-dimethyl] -1,3-dioxan-5-ol obtained in this way (yield approx. 20%) is characterized by Kp10 75 to 800 C.
Beispiel 3 120 Teil Formaldehyd-diisobutylacetal und 81 Teile Dimethyl glycerin werder in Gegenwart on katalytischen Mengen p-Toluolsulfonsäure 25 Stunden unter Rückfluß erhitzt.Example 3 120 parts of formaldehyde diisobutyl acetal and 81 parts of dimethyl glycerin is used in the presence of catalytic amounts of p-toluenesulfonic acid for 25 hours heated to reflux.
Der zunächst aus zwei Phasen hestehende Kolbeninhalt ist am Ende der Reaktion homogen. Bei einem Vakuum von etwa 35 mm Hg werden bei einer Siedetemperatur von 40 - 70°C 110 Teil Isobutylalkohol und unverbrauchtes Formaldehyd-diisobutylacetal abdestiliert. Die Fraktion Kp10 mm = 40 bis 95° C enthält 70 Teile eines Gemisches aus dem gewünschten 4,4-Dimethyl-1,3-dioxan-5-ol und seiner beiden Isomeren.The flask contents, which initially consist of two phases, are at the end of the Reaction homogeneous. At a vacuum of about 35 mm Hg will be at a boiling point from 40 - 70 ° C 110 parts isobutyl alcohol and unused formaldehyde diisobutyl acetal distilled off. The fraction Kp10 mm = 40 to 95 ° C contains 70 parts of a mixture from the desired 4,4-dimethyl-1,3-dioxan-5-ol and its two isomers.
Der Destillationsrückstand (ca. 10 - 20 Teile) enthält höher molekulare Anteile und wird verworfen.The distillation residue (approx. 10-20 parts) contains higher molecular weight Shares and is discarded.
Ds 4,4-Dimethyl-1,3-dioxan-5-ol wird durch Destillation an einer (Drehband)-Kolonne in reiner Form gewonnen; Kp10 75 bis 800 C, n2D5o = 1,4355, Ausbeute: ca. 35 % der Theorie.The 4,4-dimethyl-1,3-dioxan-5-ol is produced by distillation on a (spinning band) column obtained in pure form; Bp10 75 to 800 ° C, n2D50 = 1.4355, yield: approx. 35% of the Theory.
Beispiel 4 Die Darstellung der Ester des wie vorstehend beschrieben hergestellten 4,4-Dimethyl-1,3-dioxan-5-ols erfolgt, wenn nicht anders angegeben, durch Umsetzung der Säurechloride in Gegenwart einer Hilfsbase in Benzol oder einem anderen mit Wasser nicht mischbaren aprotonischem Lösungsmittel bei Raumtemperatur. Nach Waschen mit Wasser liegen die Ester in reiner Form vor. Auf diese Art und Weise wurden unter Verwendung der entsprechenden Ausgangsmaterialien die folgenden Ester hergestellt: Furan-(2)-carbonsäureester: Kp12 loo bis 1o50 C Nicotinsäureester: Fp. 130 bis 1350 c Stearinsäureester: Fp. 70 bis 750 C Linolensäureester: erstarrt bei -2o0 C α-Bromoisovaleinsäureester: Kp17 1o5 - 1070 C Beispiel 5 Der D-Camphersäure-a (bzw. o)-ester (1,2,2-Trimethyl-cyclopentandicarbonsäure-(1,3)-1-ester) wird durch Behandeln des Natriumsalzes vom 4,4-Dimethyl-1,3-dioxan-5-ol mit Camphersäureanhydrid in Benzol hergestellt und weist einen Schmelzpunkt von 175 his 176° C auf.Example 4 The preparation of the esters as described above 4,4-dimethyl-1,3-dioxan-5-ols produced is carried out, unless otherwise stated, by reacting the acid chlorides in the presence of an auxiliary base in benzene or a other water-immiscible aprotic solvent at room temperature. After washing with water, the esters are in pure form. That way using the appropriate starting materials, the following esters were obtained manufactured: furan (2) carboxylic acid ester: Kp12 loo to 1o50 C nicotinic acid ester: M.p. 130 to 1350 ° C. stearic acid ester: M.p. 70 to 750 ° C. linolenic acid ester: solidified at -2o0 C α-bromoisovaleic acid ester: bp17 1o5 - 1070 C. example 5 The D-camphoric acid a (or o) -ester (1,2,2-trimethyl-cyclopentanedicarboxylic acid- (1,3) -1-ester) is made by treating the sodium salt of 4,4-dimethyl-1,3-dioxan-5-ol with camphoric anhydride manufactured in benzene and has a melting point of 175 to 176 ° C.
Beispiel 6 4,4-Dimethyl-1,3-dioxan-5-ol wird in an sich bekannter Weise mit NH3 und Phosgen umgesetzt. Das Carbaminat weist einen Schmelzpunkt von 12o 1230 C auf.Example 6 4,4-Dimethyl-1,3-dioxan-5-ol is known per se Way implemented with NH3 and phosgene. The carbaminate has a melting point of 12o 1230 C.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19772740041 DE2740041A1 (en) | 1977-09-06 | 1977-09-06 | 5-Hydroxy-4,4-di:methyl-1,3-dioxan and its ester(s) - prepd. e.g. from Celastrus paniculatus seed oil and having psycho-pharmaceutical esp. memory enhancing activity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19772740041 DE2740041A1 (en) | 1977-09-06 | 1977-09-06 | 5-Hydroxy-4,4-di:methyl-1,3-dioxan and its ester(s) - prepd. e.g. from Celastrus paniculatus seed oil and having psycho-pharmaceutical esp. memory enhancing activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2740041A1 true DE2740041A1 (en) | 1979-03-08 |
Family
ID=6018219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19772740041 Ceased DE2740041A1 (en) | 1977-09-06 | 1977-09-06 | 5-Hydroxy-4,4-di:methyl-1,3-dioxan and its ester(s) - prepd. e.g. from Celastrus paniculatus seed oil and having psycho-pharmaceutical esp. memory enhancing activity |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE2740041A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8110229B2 (en) * | 2008-04-19 | 2012-02-07 | Nisarga Biotech Pvt Ltd. | Herbal composition for reducing ADD/ADHD and method thereof |
-
1977
- 1977-09-06 DE DE19772740041 patent/DE2740041A1/en not_active Ceased
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8110229B2 (en) * | 2008-04-19 | 2012-02-07 | Nisarga Biotech Pvt Ltd. | Herbal composition for reducing ADD/ADHD and method thereof |
| US8394429B2 (en) | 2008-04-19 | 2013-03-12 | Nisarga Biotech Pvt. Ltd. | Herbal composition for reducing ADD/ADHD and method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1935386C3 (en) | Optically active inner hemiacylals of cis-33-dimethyl-2-formyl-cyclopropane-1-carboxylic acids and processes for their preparation and their racemates | |
| DE1793559C3 (en) | Process for the production of furan 3 carboxylic acid esters excretion from 1543804 | |
| DE1793679B2 (en) | S-d'-R-r-X-S'-Oxo-cyclopentyl) propionic acids and their allyl esters | |
| DE2754490A1 (en) | PROCESS FOR THE PREPARATION OF 3,4-METHYLENIOXYMANDEL ACID | |
| CH395967A (en) | Process for the preparation of racemic and optically active 2,3-dimercaptosuccinic acid | |
| DE2740041A1 (en) | 5-Hydroxy-4,4-di:methyl-1,3-dioxan and its ester(s) - prepd. e.g. from Celastrus paniculatus seed oil and having psycho-pharmaceutical esp. memory enhancing activity | |
| DE2703640C2 (en) | ||
| DE1249263B (en) | Procedures for the preparation of substituted 1,3 dioxocyclopentane derivatives | |
| DE2630837C3 (en) | Process for the preparation of dihydro? -pyrons | |
| DE962256C (en) | Process for the production of serines from glycocolla and aldehydes | |
| DE1186846B (en) | Process for the preparation of 2,6-dichlorobenzonitrile | |
| DE809806C (en) | Process for the preparation of unsaturated dicarbonyl compounds | |
| DE1618053C (en) | Process for making steroid compounds | |
| DE875804C (en) | Process for the preparation of conversion products of pentaerythritol dichlorohydrin monosulfuric acid ester | |
| DE1138765B (en) | Process for the production of the Chinese acid esters of coffee | |
| DE2221123C2 (en) | Reserpic acid derivatives, processes for their preparation and pharmaceuticals | |
| DE825684C (en) | Process for the production of carboxylic acid esters | |
| DE960722C (en) | Process for the production of serines from glycocolla and aldehydes | |
| DE875803C (en) | Process for the production of pentaerythritol dichlorohydrin | |
| DE2350710C3 (en) | Method of making eriodictyol (5,7,3,4'-tetrahydroxyflavanone) | |
| DE1795740C2 (en) | 7-chloro-7-deoxy-lincomycin derivatives and pharmaceutical compositions made from these compounds and customary carriers | |
| DE1568936C3 (en) | Process for the production of benzylmalonic acid | |
| DE1054088B (en) | Process for the preparation of dehydrogenation products of piperidine and pyrrolidine | |
| DE2931887A1 (en) | METHOD FOR PRODUCING 2-ALKYL OR CYCLOALKYL-4-METHYL-6-HYDROXYPYRIMIDINES | |
| DE1518517B (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8131 | Rejection |